Celsion Corp (NASDAQ:CLSN)

Data as of Sep 19
 -0.05 / -1.62%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Celsion Corp. is an oncology drug development company which focuses on the development of treatments for those suffering with difficult to treat forms of cancer. The company's product, ThermoDox, is a liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers. It was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:



Mutual fund holders4.64%
Individual stakeholders15.13%
Other institutional10.25%

Top Executives

Michael H. TardugnoPresident, Chief Executive Officer & Director
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Vice President
Khursheed AnwerChief Scientific Officer-Nucleic Acid Therapy
Raj PrabhakarExecutive Director-Strategic Planning

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.